Table 2.
Susceptibility of S. aureus strains to ELB-21 and mitomycin C (MMC)
MIC (mg/L) |
|||
---|---|---|---|
Bacterial strain | Description | ELB-21 | MMC |
EMRSA-16 | Hospital-acquired MRSA | 0.015 | 0.03 |
NCTC 8325 | Isolated in 1960 from sepsis patient | 0.015 | 0.125 |
RN4220 | Prophage-cured derivative of NCTC 8325 | 0.03 | 0.25 |
RN450 | Prophage-cured derivative of NCTC 8325 | 0.03 | 0.25 |
RN451 | RN450 lysogenic for φ11 | 0.03 | 0.25 |
RN981 | ΔrecA derivative of RN450 | 0.00015 | 0.0075 |
RN1030 | ΔrecA derivative of RN451 | 0.000075 | 0.0075 |